|
Volumn 94, Issue 2, 2013, Pages 398-411
|
The fate of renal allografts hinges on responses of the microvascular endothelium.
a a a
a
not available
*
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD GROUP ANTIGEN;
CYTOKINE;
ENDOTHELIN 1;
ENDOTHELIN 2;
ENDOTHELIN RECEPTOR;
HLA ANTIGEN;
MEMBRANE ANTIGEN;
THROMBOMODULIN;
ALLOTRANSPLANTATION;
APOPTOSIS;
ARTICLE;
CELL LINE;
CYTOLOGY;
GENETICS;
GRAFT SURVIVAL;
HAPLOTYPE;
HUMAN;
IMMUNOLOGY;
KIDNEY;
KIDNEY TRANSPLANTATION;
METABOLISM;
MICROVASCULATURE;
PHYSIOLOGY;
UMBILICAL VEIN ENDOTHELIAL CELL;
UPREGULATION;
VASCULAR ENDOTHELIUM;
VASCULARIZATION;
VASOCONSTRICTION;
ANTIGENS, SURFACE;
APOPTOSIS;
BLOOD GROUP ANTIGENS;
CELL LINE;
CYTOKINES;
ENDOTHELIN-1;
ENDOTHELIN-2;
ENDOTHELIUM, VASCULAR;
GRAFT SURVIVAL;
HAPLOTYPES;
HLA ANTIGENS;
HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS;
HUMANS;
KIDNEY;
KIDNEY TRANSPLANTATION;
MICROVESSELS;
RECEPTORS, ENDOTHELIN;
THROMBOMODULIN;
TRANSPLANTATION, HOMOLOGOUS;
UP-REGULATION;
VASOCONSTRICTION;
|
EID: 85027945047
PISSN: None
EISSN: 10960945
Source Type: None
DOI: 10.1016/j.yexmp.2012.06.002 Document Type: Article |
Times cited : (27)
|
References (0)
|